You are on page 1of 5

Blood plasma

Blood plasma is a yellowish liquid component of blood that normally holds the
blood cells in whole blood in suspension. It is the liquid part of the blood that
carries cells and proteins throughout the body. It makes up about 55% of the
body's total blood volume.[1] It is the intravascular fluid part of extracellular
fluid (all body fluid outside cells). It is mostly water (up to 95% by volume), and
contains dissolved proteins (6–8%) (e.g. serum albumins, globulins, and
fibrinogen),[2] glucose, clotting factors, electrolytes (Na+, Ca2+, Mg2+, HCO3−,
Cl−, etc.), hormones, carbon dioxide (plasma being the main medium for
excretory product transportation) and oxygen. It plays a vital role in an
intravascular osmotic effect that keeps electrolyte concentration balanced and
protects the body from infection and other blood disorders.[3]

Blood plasma is separated from the blood by spinning a tube of fresh blood
containing an anticoagulant in a centrifuge until the blood cells fall to the bottom
of the tube. The blood plasma is then poured or drawn off.[4] Blood plasma has a
A unit of donated fresh plasma
density of approximately 1025 kg/m3, or 1.025 g/ml.[5]

Blood serum is blood plasma without clotting factors.[4]

Plasmapheresis is a medical therapy that involves blood plasma extraction, treatment, and reintegration.

Fresh frozen plasma is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health
system.[6] It is of critical importance in the treatment of many types of trauma which result in blood loss, and is therefore kept
stocked universally in all medical facilities capable of treating trauma (e.g. trauma centers, hospitals, and ambulances) or that
pose a risk of patient blood loss such as surgical suite facilities.

Blood for Britain
Plasma donation
United Kingdom
Synthetic blood plasma
See also
External links

Ion Normal concentration range (mEq.L−1)
Sodium 135–145
Potassium 3.6–5.1
Chloride 95–105
Calcium 2.0

Reference ranges for blood tests, showing normal mass concentration of blood plasma

The same information, shown in molarity rather than mass.

Blood plasma volume may be expanded by or drained to extravascular fluid when there are changes in Starling forces across
capillary walls. For example, when blood pressure drops in circulatory shock, Starling forces drive fluid into the interstitium,
causing third spacing.

Standing still for a prolonged period will cause an increase in transcapillary hydrostatic pressure. As a result, approximately 12%
of blood plasma volume will cross into the extravascular compartment. This causes an increase in hematocrit, serum total protein,
blood viscosity and, as a result of increased concentration of coagulation factors, it causes orthostatic hypercoagulability.[7]

Plasma was already well-known when described by William Harvey in de Mortu
Cordis in 1628, but knowledge of it probably extends as far back as Vesalius
(1514–1564). [8]. The discovery of fibrinogen by William Henson in ca 1770
(ibid.) made it easier to study plasma, as ordinarily, upon coming in contact with
a foreign surface – something other than vascular endothelium – clotting factors
become activated and clotting proceeds rapidly, trapping RBCs etc in the plasma
and preventing separation of plasma from the blood. Adding citrate and other
anticoagulants is a relatively recent advance. Note that, upon formation of a clot,
the remaining clear fluid (if any) is Serum (blood), which is essentially plasma
without the clotting factors. Private Roy W. Humphrey is being
given blood plasma after he was
The use of blood plasma as a substitute for whole blood and for transfusion wounded by shrapnel in Sicily in
purposes was proposed in March 1918, in the correspondence columns of the August 1943.
British Medical Journal, by Gordon R. Ward. "Dried plasmas" in powder or
strips of material format were developed and first used in World War II. Prior to
the United States' involvement in the war, liquid plasma and whole blood were used.

Blood for Britain

The "Blood for Britain" program during the early 1940s was quite successful
(and popular in the United States) based on Charles Drew's contribution. A large
project began in August 1940 to collect blood in New York City hospitals for the
export of plasma to Britain. Drew was appointed medical supervisor of the
"Plasma for Britain" project. His notable contribution at this time was to
transform the test tube methods of many blood researchers into the first
successful mass production techniques.

Nevertheless, the decision was made to develop a dried plasma package for the
armed forces as it would reduce breakage and make the transportation,
packaging, and storage much simpler.[9] The resulting dried plasma package
came in two tin cans containing 400 cc bottles. One bottle contained enough
distilled water to reconstitute the dried plasma contained within the other bottle.
In about three minutes, the plasma would be ready to use and could stay fresh for
around four hours.[10] The Blood for Britain program operated successfully for
five months, with total collections of almost 15,000 people donating blood, and
with over 5,500 vials of blood plasma.[11]
Dried plasma packages used by the
Following the "Plasma for Britain" invention, Drew was named director of the British and US militaries during WWII

Red Cross blood bank and assistant director of the National Research Council, in
charge of blood collection for the United States Army and Navy. Drew argued
against the armed forces directive that blood/plasma was to be separated by the race of the donor. Drew insisted that there was no
racial difference in human blood and that the policy would lead to needless deaths as soldiers and sailors were required to wait for
"same race" blood.[12]

By the end of the war the American Red Cross had provided enough blood for over six million plasma packages. Most of the
surplus plasma was returned to the United States for civilian use. Serum albumin replaced dried plasma for combat use during the
Korean War.[13]

Plasma donation
Plasma as a blood product prepared from blood donations is used in blood transfusions, typically as fresh frozen plasma (FFP) or
plasma Frozen Within 24 Hours After Phlebotomy (PF24). When donating whole blood or packed red blood cell (PRBC)
transfusions, O- is the most desirable and is considered a "universal donor," since it has neither A nor B antigens and can be
safely transfused to most recipients. Type AB+ is the "universal recipient" type for PRBC donations. However, for plasma the
situation is somewhat reversed. Blood donation centers will sometimes collect only plasma from AB donors through apheresis, as
their plasma does not contain the antibodies that may cross react with recipient antigens. As such, AB is often considered the
"universal donor" for plasma. Special programs exist just to cater to the male AB plasma donor, because of concerns about
transfusion related acute lung injury (TRALI) and female donors who may have higher leukocyte antibodies.[14] However, some
studies show an increased risk of TRALI despite increased leukocyte antibodies in women who have been pregnant.[15]

United Kingdom
Following fears of variant Creutzfeldt-Jakob disease (vCJD) being spread through the blood supply, the British government began
to import American plasma to meet its needs. In 2002, it purchased Life Resources Incorporated to be able to secure plasma
supply from the United States.[16] The company became Plasma Resources UK (PRUK). It owned Bio Products Laboratory. In
2013, the British government sold an 80% stake in PRUK to American hedge fund Bain Capital, in a deal estimated to be worth
£230 million.[17] The sale was met with criticism in the UK, over both the oversight of the company, and the impact on British
blood needs. Confusion arose as some thought that the blood of British blood donors voluntarily donating to NHS Blood and
Transplant Services would be sold for profit.[18] Currently, plasma donated in the United Kingdom is still not used due to
concerns about vCJD, and is incinerated after component parts have been separated from it.[18][19]

Synthetic blood plasma

Simulated body fluid (SBF) is a solution having a similar ion concentration to that of human blood plasma. SBF is normally used
for the surface modification of metallic implants, and more recently in gene delivery application.

See also
Blood plasma fractionation
Chromatography in blood processing
Hypoxia preconditioned plasma
Intravascular volume status

1. Dennis O'Neil (1999). "Blood Components" (
edu/blood/blood_components.htm). Palomar College. Archived from the original (
blood_components.htm) on June 5, 2013.
2. Tuskegee University (May 29, 2013). "Chapter 9 Blood" ( Archived from the original (htt
p:// on December 28, 2013.
3. "Ways to Keep Your Blood Plasma Healthy" (
m/plasma/plasma-donation/ways-to-keep-your-blood-plasma-healthy/). Archived from the original (http://bloodba on November 1, 2013. Retrieved
November 10, 2011.
4. Maton, Anthea; Jean Hopkins; Charles William McLaughlin; Susan Johnson; Maryanna Quon Warner; David
LaHart; Jill D. Wright (1993). Human Biology and Health. Englewood Cliffs, New Jersey, USA: Prentice Hall.
ISBN 0-13-981176-1.
5. The Physics Factbook – Density of Blood (
6. "19th WHO Model List of Essential Medicines (April 2015)" (
edicines/EML2015_8-May-15.pdf) (PDF). WHO. April 2015. Retrieved May 10, 2015.
7. Masoud M, Sarig G, Brenner B, Jacob G (June 2008). "Orthostatic hypercoagulability: a novel physiological
mechanism to activate the coagulation system". Hypertension. 51 (6): 1545–51.
doi:10.1161/HYPERTENSIONAHA.108.112003 (
PMID 18413485 (
8. Wintrobe. Blood, Pure and Eloquent.
9. Transfusion before World War I (
10. Plasma Equipment and Packaging, and Transfusion Equipment (
11. Starr, Douglas P. (2000). Blood: An Epic History of Medicine and Commerce. New York: Quill. ISBN 0-688-
12. Hirsch, Eric (1991). What Your 1st Grader Needs to Know: Fundamentals of a Good First-Grade Education. pp
232–233. New York: Doubleday.
13. The Plasma Program (
14. "AB Plasma Donor Program" ( NIH Clinical
Center. March 20, 2008. Retrieved March 18, 2011.
15. "Female Plasma May Not Increase Risk for Transfusion-Related Acute Lung Injury" (
ewarticle/564739). Medscape. October 23, 2007. Retrieved July 2, 2011.
16. "UK buys 'safe' blood supply for NHS" ( BBC News. December
17, 2002. Retrieved August 3, 2013.
17. "Bain Capital buys stake in UK government blood company" (
BBC News. July 19, 2013. Retrieved August 16, 2014.
18. "NHSBT reassures blood donors that Government's sale of PRUK does not affect them" (
overnments-sale-of-pruk-does-not-affect-them/). NHS Blood and Transplant Services.
19. Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory
Committee. "Position Statement on Creutzfeldt–Jakob Disease" (
D%20May%202015.pdf) (PDF). Retrieved August 10, 2016.

External links
Blood plasma pioneer, English physician Gordon R. Ward (

Retrieved from ""

This page was last edited on 11 June 2019, at 06:43 (UTC).

Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using
this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia
Foundation, Inc., a non-profit organization.